Bangstad HJ - Search Results

1

Aberrant heparan sulfate profile in the human diabetic kidney offers new clues for therapeutic glycomimetics.

Wijnhoven TJ, Lensen JF, Rops AL, van der Vlag J, Kolset SO, Bangstad HJ, Pfeffer P, van den Hoven MJ, Berden JH, van den Heuvel LP, van Kuppevelt TH. Wijnhoven TJ, et al. Among authors: bangstad hj. Am J Kidney Dis. 2006 Aug;48(2):250-61. doi: 10.1053/j.ajkd.2006.05.003. Am J Kidney Dis. 2006. PMID: 16860191

2

[Advanced glycation end products and hyperglycaemia].

Omsland TK, Bangstad HJ, Berg TJ, Kolset SO. Omsland TK, et al. Among authors: bangstad hj. Tidsskr Nor Laegeforen. 2006 Jan 12;126(2):155-8. Tidsskr Nor Laegeforen. 2006. PMID: 16415936 Free article. Review. Norwegian.

3

Matrix metalloproteinases in subjects with type 1 diabetes.

Gharagozlian S, Svennevig K, Bangstad HJ, Winberg JO, Kolset SO. Gharagozlian S, et al. Among authors: bangstad hj. BMC Clin Pathol. 2009 Sep 16;9:7. doi: 10.1186/1472-6890-9-7. BMC Clin Pathol. 2009. PMID: 19758433 Free PMC article.

4

Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus.

Berg TJ, Bangstad HJ, Torjesen PA, Osterby R, Bucala R, Hanssen KF. Berg TJ, et al. Among authors: bangstad hj. Metabolism. 1997 Jun;46(6):661-5. doi: 10.1016/s0026-0495(97)90010-x. Metabolism. 1997. PMID: 9186302 Clinical Trial.

5

Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus.

Dahl-Jørgensen K, Bjøro T, Kierulf P, Sandvik L, Bangstad HJ, Hanssen KF. Dahl-Jørgensen K, et al. Among authors: bangstad hj. Kidney Int. 1992 Apr;41(4):920-3. doi: 10.1038/ki.1992.140. Kidney Int. 1992. PMID: 1513113 Free article. Clinical Trial.

6

[ACE inhibitors and early diabetic nephropathy].

Bangstad HJ, Hartmann A, Berg TJ, Hanssen KF. Bangstad HJ, et al. Tidsskr Nor Laegeforen. 1995 Oct 10;115(24):3039-41. Tidsskr Nor Laegeforen. 1995. PMID: 7570536 Review. Norwegian.

7

The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes.

Berg TJ, Clausen JT, Torjesen PA, Dahl-Jørgensen K, Bangstad HJ, Hanssen KF. Berg TJ, et al. Among authors: bangstad hj. Diabetes Care. 1998 Nov;21(11):1997-2002. doi: 10.2337/diacare.21.11.1997. Diabetes Care. 1998. PMID: 9802757

8

Renal tubulointerstitial expansion is associated with endothelial dysfunction and inflammation in type 1 diabetes.

Bangstad HJ, Seljeflot I, Berg TJ, Hanssen KF. Bangstad HJ, et al. Scand J Clin Lab Invest. 2009;69(1):138-44. doi: 10.1080/00365510802444080. Scand J Clin Lab Invest. 2009. PMID: 18846477

9

Hydroperoxides in plasma are reduced by intensified insulin treatment. A randomized controlled study of IDDM patients with microalbuminuria.

Berg TJ, Nourooz-Zadeh J, Wolff SP, Tritschler HJ, Bangstad HJ, Hanssen KF. Berg TJ, et al. Among authors: bangstad hj. Diabetes Care. 1998 Aug;21(8):1295-300. doi: 10.2337/diacare.21.8.1295. Diabetes Care. 1998. PMID: 9702436 Clinical Trial.

10

Severity of glomerulopathy predicts long-term urinary albumin excretion rate in patients with type 1 diabetes and microalbuminuria.

Bangstad HJ, Osterby R, Hartmann A, Berg TJ, Hanssen KF. Bangstad HJ, et al. Diabetes Care. 1999 Feb;22(2):314-9. doi: 10.2337/diacare.22.2.314. Diabetes Care. 1999. PMID: 10333951

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters